CRIS Current Research Information System

RE, MARIA CARLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.473
EU - Europa 5.684
AS - Asia 2.573
AF - Africa 430
SA - Sud America 24
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 7
Totale 16.205
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.455
IT - Italia 1.249
GB - Regno Unito 1.215
SE - Svezia 1.067
CN - Cina 897
DE - Germania 820
SG - Singapore 582
VN - Vietnam 568
IN - India 329
IE - Irlanda 266
UA - Ucraina 249
FR - Francia 216
TG - Togo 182
RU - Federazione Russa 177
ZA - Sudafrica 99
BG - Bulgaria 86
EE - Estonia 83
JO - Giordania 81
NG - Nigeria 64
CI - Costa d'Avorio 59
BE - Belgio 53
CH - Svizzera 40
AT - Austria 26
FI - Finlandia 26
HR - Croazia 24
ID - Indonesia 23
HK - Hong Kong 22
PT - Portogallo 17
SC - Seychelles 17
CA - Canada 15
NL - Olanda 15
IR - Iran 13
BR - Brasile 12
JP - Giappone 11
RO - Romania 11
AU - Australia 10
UZ - Uzbekistan 10
CL - Cile 8
PL - Polonia 8
ES - Italia 7
GR - Grecia 7
LB - Libano 7
TR - Turchia 7
CZ - Repubblica Ceca 6
EG - Egitto 5
PH - Filippine 5
EU - Europa 4
IL - Israele 4
NZ - Nuova Zelanda 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DK - Danimarca 3
HU - Ungheria 3
MK - Macedonia 3
BD - Bangladesh 2
CM - Camerun 2
MX - Messico 2
MY - Malesia 2
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
EC - Ecuador 1
ET - Etiopia 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MS - Montserrat 1
NO - Norvegia 1
PK - Pakistan 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VE - Venezuela 1
Totale 16.205
Salva come PNG Salva come JPEG
Città #
Southend 1.082
Fairfield 909
Chandler 736
Ashburn 589
Singapore 503
Ann Arbor 497
Woodbridge 433
Seattle 419
Dong Ket 410
Houston 408
Wilmington 372
Princeton 337
Cambridge 327
Dublin 266
Bologna 238
Lomé 182
Jacksonville 147
Frankfurt am Main 132
Westminster 130
Nanjing 126
Berlin 109
Padova 94
Santa Clara 92
Turin 89
Redmond 84
Sofia 82
Amman 81
Beijing 79
San Diego 68
Florence 67
Milan 65
Des Moines 64
Abeokuta 63
Jinan 63
Abidjan 59
Shenyang 56
Saint Petersburg 53
Bremen 51
Brussels 50
New York 49
Hebei 46
Boardman 38
Rome 35
Tianjin 33
Mülheim 31
Los Angeles 30
Dearborn 29
Falls Church 29
Nanchang 29
Olalla 29
Bern 28
Redwood City 28
Jakarta 23
Changsha 22
Guangzhou 22
London 22
Paris 22
Zhengzhou 22
Hangzhou 21
Helsinki 21
Ningbo 21
Vienna 20
Bühl 19
Jiaxing 19
Monmouth Junction 19
Chicago 18
Shanghai 18
Phoenix 17
Taiyuan 16
Lanzhou 15
Mahé 15
Norwalk 14
Haikou 13
Kuban 13
Kunming 13
Taizhou 13
Verona 13
Hong Kong 12
Medford 12
Naples 12
Wuhan 12
Atlanta 11
Pune 11
San Venanzo 11
Shenzhen 10
Costa Mesa 9
Muizenberg 9
Napoli 9
Toronto 9
Xi'an 9
Ardabil 8
Cagliari 8
Ferrara 8
Fuzhou 8
Hyderabad 8
San Jose 8
Amsterdam 7
Catania 7
Chengdu 7
Hefei 7
Totale 10.709
Salva come PNG Salva come JPEG
Nome #
Analisi della trasmissione di SARS-CoV-2: influenza delle condizioni termoigrometriche rispetto al rischio di diffusione del contagio 235
ALTERAZIONI DEL MICROBIOMA FARINGEO IN CORSO DI INFEZIONI DA NEISSERIA GONORRHOEAE 224
QuantiFERON-TB Gold Plus with Chemiluminescence Immunoassay: Do We Need a Higher Cutoff? 215
Acute onset myopericarditis as unusual presentation of primary HIV infection 189
RILEVAZIONE DELLA STRUTTURA MOSAICO DEL GENE PENA IN SEDE ORO-FARINGEA 182
Analysis of the effects of HIV-1 Tat on the survival and differentiation of vessel wall-derived mesenchymal stem cells 174
Impact of meropenem on Klebsiella pneumoniae metabolism 173
Serum antibodies against human intracisternal A-type particle (HIAP) endogenous retrovirus in Alopecia areata patients: a hallmark of autoimmune disease? 169
Pharyngeal Chlamydia and gonorrhea: a hidden problem 168
18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy 162
Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naive HIV-1 patients with acute and chronic infection 157
Comparison of the Aptima HIV-1 Quant Dx Assay with the COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 v2.0 Test for HIV-1 Viral Load Quantification in Plasma Samples from HIV-1-Infected Patients. 157
Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique. 156
Mosaic structure of the penA gene in the oropharynx of men who have sex with men negative for gonorrhoea 153
Discordant resistance interpretations in multi-treated HIV-1 patients 149
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 149
Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1 149
Autochthonous cases of mucosal leishmaniasis in Northeastern Italy: clinical management and novel treatment approaches 148
Serum antibody reactivity to human intracisternal A-type particle retrovirus proteins in systemic sclerosis patients 145
IFI16 expression is related to selected transcription factors during B-cell differentiation 140
HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients. 137
HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells 133
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy 133
Improvement of Mycobacterium tuberculosis detection by Xpert MTB/RIF Ultra: A head-to-head comparison on Xpert-negative samples 131
Antiretroviral molecules and cardiovascular diseases. 128
Asymptomatic Leishmania infantum infection in blood donors living in an endemic area, northeastern Italy 128
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 128
Analysis of the effects of specific protease inhibitors on OPG/RANKL regulation in an osteoblast-like cell line. 126
Clinical application of Bruker Biotyper MALDI-TOF/MS system for real-time identification of KPC production in Klebsiella pneumoniae clinical isolates 126
Encephalopathy in COVID-19 Presenting With Acute Aphasia Mimicking Stroke 126
M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures 126
Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures. 125
Low-dose doxycycline induces Chlamydia trachomatis persistence in HeLa cells 125
HIV-1 and HCV detection in dried blood spots by SYBR Green multiplex real-time RT-PCR. 124
Pharyngeal microbiome alterations during Neisseria gonorrhoeae infection 124
Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients. 123
Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz 123
Recent and long-lasting infections: the need for avidity testing in HIV-1 infected subjects. 122
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors 122
Detection of serum antibodies to human intracisternal A-type retroviral particles in chronic idiopathic urticaria 121
Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection. 121
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods 121
Host restriction factors and Human immunodeficiency Virus (HIV-1): a dynamic interplay involving all phases of the viral life cycle 120
Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV-1 patients. 119
Antiretroviral Activity of Thiosemicarbazone Metal Complexes 119
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns 119
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization 119
HIV-1 subtype C transmission network: The phylogenetic reconstruction strongly supports the epidemiological data. 119
Incomplete IgG response to HIV-1 proteins and low avidity levels in recently converted HIV patients treated with early antiretroviral therapy. 118
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice 117
Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages. 116
An imported case of adult T cell leukemia in a HTLV-I-infected patient in Italy. 116
HIV-related mechanisms in atherosclerosis and cardiovascular diseases. 115
Effects of Antiretroviral Molecules on Survival and Gene Expression of an Osteoblast-like Cell Line 115
Rectal Microbiota Associated With Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Men Having Sex With Other Men 115
HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals. 114
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen 113
Impact of different antiretroviral strategies on total HIV-DNA level in virologically suppressed HIV-1 infected patients. 113
Molecular Bases of Osteoporosis in HIV: The Role of the Virus and Antiretroviral Therapy 113
Different patterns of HIV-1 DNA after therapy discontinuation 113
Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results 113
null 113
SARS-CoV-2/COVID-19 testing: The tower of babel 113
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. 112
Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy. 112
HIV-1 infection of a nurse from a newborn with an unknown HIV infection: a case report. 111
HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity 111
Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz 109
No correlation between statin exposure and incident diabetes mellitus in HIV-1-infected patients receiving combination antiretroviral therapy 108
HIV and kidney: A dangerous liaison 108
Bone alterations during HIV infection 108
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting. 107
Guidelines for the qualitative detection of viral genomes in dried blood spots. 107
Children and SARS-CoV-2 infection: innocent bystanders…until proven otherwise 107
Comparison of MycoPrep and the new MYCO-TB kit: rapid and efficient digestion and decontamination of respiratory specimens for the detection of Mycobacteria 106
Carbapenemase-producing Enterobacterales: changing epidemiology in a highly endemic Italian area 106
Pre-Pregnancy Diet and Vaginal Environment in Caucasian Pregnant Women: An Exploratory Study 106
Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy. 105
Cap. 4- IL MICROBIOMA OCULARE E IMPATTO SUL SISTEMA IMMUNE 105
HIV-1 early and late diagnosis in the Emilia Romagna Region (Italy): A three year study 104
Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients 104
Emerging mutations at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine. 103
High-throughput genotyping of high-risk Human Papillomavirus by MALDI-TOF Mass Spectrometry-based method. 103
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 103
HIV-1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy 102
Analysis of HIV-1 drug-resistant variants in plasma and peripheral blood mononuclear cells from untreated individuals: implications for clinical management. 102
Two cases of relapsed HIV-associated visceral leishmaniasis successfully treated with combination therapy 102
HIV-1 Tat protein enhances RANKL/M-CSF-mediated osteoclast differentiation. 101
Dynamics of HIV viral load in blood and semen of patients under HAART: impact of therapy in assisted reproduction procedures. 100
V3 net charge: additional tool in HIV-1 tropism prediction 100
Low avidity antibody: a reliable method to diagnose a recent HIV-1 infection. 99
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 98
Screening strategies for the diagnosis of asymptomatic Leishmania infection in dialysis patients as a model for kidney transplant candidates 97
Quantitative detection of human immunodeficiency virus type 1 (HIV-1) viral load by SYBR green real-time RT-PCR technique in HIV-1 seropositive patients. 96
Effect of sugars on Chlamydia trachomatis infectivity 96
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: Results from the DIVA study group 95
Simultaneous detection of HCV and HIV-1 by SYBR Green real time multiplex RT-PCR technique in plasma samples. 95
Nevirapine prophylaxis to prevent HIV-1 mother-to-child transmission: pharmacokinetic considerations in preterm infants 94
Quantitative HIV-1 proviral DNA detection: a multicentre analysis. 93
Metabolic bone disease in HIV infection 93
Totale 12.407
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.712
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.805 0 0 0 186 347 323 397 447 496 248 198 163
2020/20212.662 488 144 141 109 89 140 47 130 312 170 127 765
2021/20223.542 245 194 205 414 295 188 73 228 132 463 630 475
2022/20233.753 398 525 219 508 286 241 106 219 617 136 321 177
2023/20241.065 74 166 83 119 89 219 70 71 22 71 40 41
2024/20251.264 163 607 312 182 0 0 0 0 0 0 0 0
Totale 16.715